Eureka TechIN invested Star Combo prior to its’s listing on the Sydney Australian Stock Exchange (ASX). The company has been able to maintain thecontinuous double-digit growth and will continue to expand the current operations to create benefits for serve business partners, customers and employees.

​

Eureka TechIN became shareholder of INWENTECH in November 2019 and assisted INWENTECH set up a branch office in Jinan, China to access the valuable  Chinese and surrounding Asian markets.

​

​

​

​

Eureka TechIN recognizeds the R&D capabilities in of Oculus BioMed (OBM) and are very confident in the prospects within the growth opportunities in theing ophthalmic and biomedical market. In October of 2019, Eureka TechIN became a shareholder of OBM and enableboost it to explore broaderbigger Asian market. 

​